Insider Stock Trading History of Torley Helen


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Torley Helen since year 2005. The trader's CIK number is 1528185. At the time of this reporting, Torley Helen is the President and CEO of Halozyme Therapeutics Inc . (stock ticker symbol HTI). See this page for all insider trading activities at Halozyme Therapeutics Inc .

Note that in the past Torley Helen also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Torley Helen since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-06 HALO Halozyme Therapeutics Inc Option Ex 31,250 .00 0
2017-02-03 HALO Halozyme Therapeutics Inc Option Ex 55,487 .00 0
2017-01-06 HALO Halozyme Therapeutics Inc Option Ex 30,000 .00 0
2016-06-30 HALO Halozyme Therapeutics Inc Option Ex 13,500 .00 0
2016-06-07 RLYP Relypsa Inc Sale 1,013 19.32 19,570
2016-02-06 HALO Halozyme Therapeutics Inc Option Ex 31,250 .00 0
2016-01-06 HALO Halozyme Therapeutics Inc Option Ex 30,000 .00 0
2015-01-06 HALO Halozyme Therapeutics Inc Option Ex 30,000 .00 0
2014-09-16 HALO Halozyme Therapeutics Inc Buy 50,000 8.92 446,000
2013-08-12 ONXX Onyx Pharmaceuticals Inc Option Ex 8,250 35.69 294,442
2013-08-12 ONXX Onyx Pharmaceuticals Inc Sale 9,311 126.91 1,181,621
2013-05-13 ONXX Onyx Pharmaceuticals Inc Sale 8,250 97.91 807,757
2013-05-13 ONXX Onyx Pharmaceuticals Inc Option Ex 8,250 35.69 294,442
2013-04-01 ONXX Onyx Pharmaceuticals Inc Sale 466 86.14 40,141
2013-02-04 ONXX Onyx Pharmaceuticals Inc Option Ex 8,250 35.69 294,442
2013-02-04 ONXX Onyx Pharmaceuticals Inc Sale 8,250 78.61 648,532
2012-11-12 ONXX Onyx Pharmaceuticals Inc Sale 11,997 75.22 902,414
2012-11-12 ONXX Onyx Pharmaceuticals Inc Option Ex 8,250 35.69 294,442
2012-10-04 ONXX Onyx Pharmaceuticals Inc Sale 2,314 86.51 200,184
2012-09-04 ONXX Onyx Pharmaceuticals Inc Sale 1,878 72.78 136,680
2012-08-06 ONXX Onyx Pharmaceuticals Inc Sale 2,000 71.89 143,780
2012-07-25 ONXX Onyx Pharmaceuticals Inc Sale 4,549 73.97 336,498

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Torley Helen (President and CEO of Halozyme Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.